Is Nerve-Sparing Surgery Possible in Prostate Cancer?

Yes, nerve-sparing surgery is possible for many prostate cancer patients, provided the tumour hasn’t grown into the neurovascular bundles running along either side of the gland. Not always, though. It’s a case-by-case call. The decision comes down to cancer stage, tumour location, and how aggressive things look on biopsy. When it’s feasible, surgeons preserve the nerves that handle erectile function and continence while still clearing the cancer completely. When it isn’t, complete removal wins. Every time.

According to Prof. Dr. Sandeep Nayak, Robotic Cancer Surgery in Bangalore, “Nerve sparing only works when the cancer’s location actually allows it, and that’s something the anatomy on the table decides, not the scan taken beforehand.”

A handful of concrete factors decide this. Case by case, never by default.

• Tumour location. If the cancer sits close to where the neurovascular bundles run, surgeons often sacrifice function on that side to stay ahead of the disease.
• Cancer stage. Early, organ-confined tumours leave far more room to work with than disease that’s already pushed past the capsule.
• Gleason score. Because leaving cancer behind costs more than losing function ever would, higher grade disease pushes surgeons toward a wider resection margin.
• Baseline function. Men with some erectile difficulty going in simply don’t gain as much from nerve sparing, so that gets weighed upfront, honestly.

A detailed prostate evaluation covering imaging and biopsy mapping decides this, not guesswork, before surgery ever begins.

Results vary considerably here. Worth being honest about that range instead of promising a number that won’t hold for everyone.

• Bilateral sparing. Preserving both neurovascular bundles pushes potency recovery meaningfully higher, sometimes well above 70% in younger, healthier men.
• Unilateral sparing. Saving just one bundle still helps, though the numbers drop and recovery tends to stretch out longer.
• Recovery timeline. Nerves heal slowly, and it can take six months to two years for function to return, which is normal, not a failure of the surgery.
• Robotic precision. So magnified 3D visualisation lets surgeons dissect closer to the nerves without the thermal damage older techniques often caused.

Much of this overlaps with what gets discussed during stage 2 prostate cancer planning too, where staging shapes strategy directly.